Clinical Trial Update: Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating a triple antiemetic regimen for chemoradiotherapy in cervical cancer or nasopharyngeal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Nasopharyngeal Cancer

Snippet

Sponsor: Shantou University Medical College | Conditions: Cervical Cancer, Nasopharyngeal Cancer | Phase 3 | Status: COMPLETED